Evaluation of the MiStent sustained sirolimus eluting biodegradable polymer coated stent for the treatment of coronary artery disease: does uniform sustained abluminal drug release result in earlier strut coverage and better safety profile?-Reference-Cited by-同舟云学术

Evaluation of the MiStent sustained sirolimus eluting biodegradable polymer coated stent for the treatment of coronary artery disease: does uniform sustained abluminal drug release result in earlier strut coverage and better safety profile?

Published:2017-04-24 Issue:5 Volume:14 Page:325-334
ISSN:1743-4440
Container-title:Expert Review of Medical Devices
language:en
Short-container-title:Expert Review of Medical Devices

Author:

Tijssen Ruben Y.G.¹,Kraak Robin P.¹,Lu Huangling¹,Mifek Jeffrey G.²,Carlyle Wenda C.²,Donohoe Dennis J.²,De Winter Robbert J.¹,Koch Karel T.¹,Wykrzykowska Joanna J.¹

Affiliation:

1. AMC Heartcenter, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

2. Micell Technologies INC, Durham, NC, USA

Publisher

Informa UK Limited

Subject

Biomedical Engineering,General Medicine,Surgery

Link

https://www.tandfonline.com/doi/pdf/10.1080/17434440.2017.1318057

Reference39 articles.

1. Coronary-Artery Stents

2. New Drug-Eluting Stents